Health risk assessment related to pinnatoxins in French shellfish.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 08 10 2019
revised: 16 03 2020
accepted: 25 03 2020
pubmed: 5 4 2020
medline: 15 5 2020
entrez: 5 4 2020
Statut: ppublish

Résumé

Pinnatoxins (PnTXs) are a group of emerging marine biotoxins produced by the benthic dinoflagellate Vulcanodinium rugosum, currently not regulated in Europe or in any other country in the world. In France, PnTXs were detected for the first time in 2011, in mussels from the Ingril lagoon (South of France, Mediterranean coast). Since then, analyses carried out in mussels from this lagoon have shown high concentrations of PnTXs for several months each year. PnTXs have also been detected, to a lesser extent, in mussels from other Mediterranean lagoons and on the Atlantic and Corsican coasts. In the French data, the main analog is PnTX G (low levels of PnTX A are also present in some samples). No cases of PnTXs poisoning in humans have been reported so far in France or anywhere else in the world. In mice, PnTXs induce acute neurotoxic effects, within a few minutes after oral administration. Clinical signs of toxicity include decreased mobility, paralysis of the hind legs, tremors, jumps and breathing difficulties leading to death by respiratory arrest at high doses. The French agency for food safety (ANSES) recently conducted a review of the state of knowledge related to PnTXs and V. rugosum. Based on (i) the clinical signs of toxicity in mice, (ii) the mode of action of PnTXs as nicotinic acetylcholine receptor competitive antagonists and (iii) knowledge on drugs and natural toxins with PnTX-related pharmacology, potential human symptoms have been extrapolated and proposed. In this work, a provisional acute benchmark value for PnTX G of 0.13 μg/kg bw per day has been derived from an oral acute toxicity study in mice. Based on this value and a large shellfish meat portion size of 400g, a concentration lower than 23 μg PnTX G/kg shellfish meat is not expected to result in adverse effects in humans. ANSES recommends taking into account PnTXs in the French official monitoring program for shellfish production and identified data gaps to refine health risk assessment.

Identifiants

pubmed: 32246951
pii: S0041-0101(20)30098-2
doi: 10.1016/j.toxicon.2020.03.007
pii:
doi:

Substances chimiques

Marine Toxins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest. The authors’ declarations of interests are made public via the ANSES website (www.anses.fr).

Auteurs

Nathalie Arnich (N)

ANSES (French Agency for Food, Environmental and Occupational Health and Safety), Risk Assessment Directorate, Maisons-Alfort, France. Electronic address: nathalie.arnich@anses.fr.

Eric Abadie (E)

MARBEC, Université de Montpellier, CNRS, Ifremer, IRD, Sète, France.

Nicolas Delcourt (N)

Poison Control Centre, Toulouse-Purpan University Hospital and Toulouse NeuroImaging Centre (ToNIC), Toulouse, France.

Valérie Fessard (V)

ANSES (French Agency for Food, Environmental and Occupational Health and Safety), Toxicology of Contaminants Unit, Fougères, France.

Jean-Marc Fremy (JM)

ANSES (French Agency for Food, Environmental and Occupational Health and Safety), Laboratory for Food Safety, Maisons-Alfort, France.

Vincent Hort (V)

ANSES (French Agency for Food, Environmental and Occupational Health and Safety), Laboratory for Food Safety, Maisons-Alfort, France.

Emmeline Lagrange (E)

Department of Neurology, Reference Center of Neuromuscular Disease, Grenoble University Hospital, France.

Thomas Maignien (T)

ANSES (French Agency for Food, Environmental and Occupational Health and Safety), Risk Assessment Directorate, Maisons-Alfort, France.

Jordi Molgó (J)

CEA (French Alternative Energies and Atomic Energy Commission), CNRS, Gif-sur-Yvette, France.

Marie-Bénédicte Peyrat (MB)

ANSES (French Agency for Food, Environmental and Occupational Health and Safety), Risk Assessment Directorate, Maisons-Alfort, France.

Jean-Paul Vernoux (JP)

Normandie University, Caen, France.

César Mattei (C)

Mitochondrial and Cardiovascular Pathophysiology, UMR CNRS 6015, INSERM U1083, Angers University, Angers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH